Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03786081
Title Safety and Efficacy of Tisotumab Vedotin in Combination With Other Cancer Agents in Subjects With Cervical Cancer
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Genmab

cervical adenosquamous carcinoma

cervical adenocarcinoma

cervical squamous cell carcinoma


Bevacizumab + Tisotumab vedotin-tftv

Carboplatin + Tisotumab vedotin-tftv

Pembrolizumab + Tisotumab vedotin-tftv

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | BEL

No variant requirements are available.